{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:51:41Z","timestamp":1795107101565,"version":"4.10.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Statins or 3\u2011hydroxy\u20113\u2011methyl\u2011glutarylcoenzyme A (HMG\u2011CoA) reductase inhibitors are medications that act by reducing the cholesterol content of liver cells Moreover, statins have been found to improve endothelial function and reduce vascular wall inflammation. A growing body of research suggests that statins are associated with less risk of migraine, and they can be used to treat symptoms. However, the evidence has been inconclusive, so we aim to investigate the nature and strength of the effect of statins on the prevention and prophylaxis of migraines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a comprehensive systematic search across multiple electronic databases, including PubMed, Scopus, Web of Science, and the Cochrane Library, from inception until October 2024, to include studies on the association between statins use and migraine. The outcomes of interest involved the association of the HMG-CoA reductase gene with the risk of migraine, as well as the association and efficacy of statins in migraine patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirteen studies were included in our systematic review. Mendelian Randomization (MR) studies revealed that expression of HMGCR was associated with an increased risk of migraine with odds ratio (OR) ranging from 1.38 to 1.55 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Three observational studies investigating the relationship between statins and migraine risk demonstrated a protective effect, with odds ratios ranging from 0.73 to 0.94 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The findings suggest a significant reduction in overall migraine risk, particularly for migraines with aura and in patients with higher vitamin D levels. Meta-analysis of randomized controlled trials (RCTs) showed that statins significantly reduced monthly migraine frequency (MD= -3.16, 95%CI= [-5.79, -0.53]; <jats:italic>p<\/jats:italic>\u2009=\u20090.02, I2\u2009=\u200979%; <jats:italic>P<\/jats:italic>\u2009=\u20090.03). RCTs supported the efficacy of statins in reducing migraine frequency, days, and intensity compared to placebo.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Statins, already well-established for cardiovascular benefits, emerge as a promising dual-purpose therapy for many neurological disorders. The association between the HMGCR gene and increased migraine risk, coupled with the possible efficacy of statins in reducing migraine frequency, may open new avenues for migraine prophylaxis. However, the variability in study design hinders definitive conclusions, so larger studies with longer follow-ups are required to ascertain both findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s10194-025-01957-w","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:41:57Z","timestamp":1738586517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0907-4475","authenticated-orcid":false,"given":"Hamdy A.","family":"Makhlouf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-9268","authenticated-orcid":false,"given":"Amr K.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-7059","authenticated-orcid":false,"given":"Nereen A.","family":"Almosilhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2871-9925","authenticated-orcid":false,"given":"Ahmed S.A.","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrouk","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0511-2429","authenticated-orcid":false,"given":"Moaz Elsayed","family":"Abouelmagd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"1957_CR1","doi-asserted-by":"publisher","unstructured":"Stovner L, Hagen K, Jensen R, et al (2007) The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide. Cephalalgia 27:193\u2013210. https:\/\/doi.org\/10.1111\/j.1468-2982.2007.01288.x.","DOI":"10.1111\/j.1468-2982.2007.01288.x"},{"key":"1957_CR2","doi-asserted-by":"publisher","unstructured":"Lima AM, Sapienza GB, Giraud VO, Fragoso YD (2011) Odors as triggering and worsening factors for migraine in men. Arq Neuropsiquiatr 69:324\u2013327. https:\/\/doi.org\/10.1590\/S0004-282X2011000300011.","DOI":"10.1590\/S0004-282X2011000300011"},{"key":"1957_CR3","doi-asserted-by":"publisher","unstructured":"Vos T, Abajobir AA, Abate KH, et al (2017) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet 390:1211\u20131259. https:\/\/doi.org\/10.1016\/S0140-6736(17)32154-2.","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"1957_CR4","doi-asserted-by":"publisher","unstructured":"Stewart WF, Linet MS, Celentano DD, et al (1991) Age- and Sex-specific Incidence Rates of Migraine with and without Visual Aura. Am J Epidemiol 134:1111\u20131120. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116014.","DOI":"10.1093\/oxfordjournals.aje.a116014"},{"key":"1957_CR5","doi-asserted-by":"publisher","unstructured":"Evers S, \u00c1fra J, Frese A, et al (2009) EFNS guideline on the drug treatment of migraine\u2013 revised report of an EFNS task force. Eur J Neurol 16:968\u2013981. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02748.x.","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"key":"1957_CR6","doi-asserted-by":"crossref","unstructured":"Tronvik E, Giri S, Young W (2024) Preventive treatment of migraine: Non-specific oral agents. In: Handbook of Clinical Neurology. Elsevier, pp 67\u201386","DOI":"10.1016\/B978-0-12-823357-3.00009-4"},{"key":"1957_CR7","doi-asserted-by":"publisher","unstructured":"Vaughan CJ, Gotto AM, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35:1\u201310. https:\/\/doi.org\/10.1016\/S0735-1097(99)00525-2.","DOI":"10.1016\/S0735-1097(99)00525-2"},{"key":"1957_CR8","doi-asserted-by":"publisher","unstructured":"Tousoulis D, Psarros C, Demosthenous M, et al (2014) Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease. J Am Coll Cardiol 63:2491\u20132502. https:\/\/doi.org\/10.1016\/j.jacc.2014.01.054.","DOI":"10.1016\/j.jacc.2014.01.054"},{"key":"1957_CR9","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM, Al\u2010Gareeb AI, Alexiou A, et al (2023) Pros and cons for statins use and risk of Parkinson\u2019s disease: An updated perspective. Pharmacol Res Perspect 11:e01063. https:\/\/doi.org\/10.1002\/prp2.1063.","DOI":"10.1002\/prp2.1063"},{"key":"1957_CR10","doi-asserted-by":"publisher","unstructured":"Mady A, Nabil Y, Daoud A, et al (2024) Determining the role of statins in Parkinson\u2019s disease risk reduction and disease modification: A comprehensive meta-analysis of 4\u00a0million participants\u2019 data. CNS Neurosci Ther 30:e14888. https:\/\/doi.org\/10.1111\/cns.14888.","DOI":"10.1111\/cns.14888"},{"key":"1957_CR11","doi-asserted-by":"publisher","unstructured":"Kursun O, Yemisci M, Van Den Maagdenberg AMJM, Karatas H (2021) Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain 22:55. https:\/\/doi.org\/10.1186\/s10194-021-01271-1.","DOI":"10.1186\/s10194-021-01271-1"},{"key":"1957_CR12","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Alonso-Navarro H, Garc\u00eda-Mart\u00edn E, et al (2024) Oxidative Stress and Migraine. Mol Neurobiol 61:8344\u20138360. https:\/\/doi.org\/10.1007\/s12035-024-04114-7.","DOI":"10.1007\/s12035-024-04114-7"},{"key":"1957_CR13","doi-asserted-by":"publisher","unstructured":"Qu K, Li M, Yu P, et al (2024) HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study. Sci Rep 14:12094. https:\/\/doi.org\/10.1038\/s41598-024-61628-9.","DOI":"10.1038\/s41598-024-61628-9"},{"key":"1957_CR14","doi-asserted-by":"publisher","unstructured":"Buettner C, Burstein R (2015) Association of statin use and risk for severe headache or migraine by serum vitamin D status: A cross-sectional population-based study. Cephalalgia 35:757\u2013766. https:\/\/doi.org\/10.1177\/0333102414559733.","DOI":"10.1177\/0333102414559733"},{"key":"1957_CR15","doi-asserted-by":"publisher","unstructured":"Buettner C, Nir R, Bertisch SM, et al (2015) Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol 78:970\u2013981. https:\/\/doi.org\/10.1002\/ana.24534.","DOI":"10.1002\/ana.24534"},{"key":"1957_CR16","doi-asserted-by":"publisher","unstructured":"Hong P, Han L, Wan Y (2024) Mendelian randomization study of lipid metabolism characteristics and migraine risk. Eur J Pain 28:978\u2013986. https:\/\/doi.org\/10.1002\/ejp.2235.","DOI":"10.1002\/ejp.2235"},{"key":"1957_CR17","unstructured":"Higgins JPT, Green S, Cochrane Collaboration (2021) Cochrane handbook for systematic reviews of interventions version 6.2 [updated February 2021] Cochrane. Wiley-Blackwell, Chichester, England; Hoboken, NJ"},{"key":"1957_CR18","doi-asserted-by":"publisher","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ n71. https:\/\/doi.org\/10.1136\/bmj.n71.","DOI":"10.1136\/bmj.n71"},{"key":"1957_CR19","doi-asserted-by":"publisher","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev 5:210. https:\/\/doi.org\/10.1186\/s13643-016-0384-4.","DOI":"10.1186\/s13643-016-0384-4"},{"key":"1957_CR20","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ l4898. https:\/\/doi.org\/10.1136\/bmj.l4898.","DOI":"10.1136\/bmj.l4898"},{"key":"1957_CR21","unstructured":"Wells, George A, Shea, Beverly, O\u2019Connell D, et al (2004) The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses."},{"key":"1957_CR22","doi-asserted-by":"publisher","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177\u2013188. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"1957_CR23","doi-asserted-by":"publisher","unstructured":"Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558. https:\/\/doi.org\/10.1002\/sim.1186.","DOI":"10.1002\/sim.1186"},{"key":"1957_CR24","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Egger M, Smith GD (2001) Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 323:101\u2013105. https:\/\/doi.org\/10.1136\/bmj.323.7304.101.","DOI":"10.1136\/bmj.323.7304.101"},{"key":"1957_CR25","doi-asserted-by":"publisher","unstructured":"Ganji R, Majdinasab N, Hesam S, et al (2021) Does atorvastatin have augmentative effects with sodium valproate in prevention of migraine with aura attacks? A triple-blind controlled clinical trial. J Pharm Health Care Sci 7:12. https:\/\/doi.org\/10.1186\/s40780-021-00198-8.","DOI":"10.1186\/s40780-021-00198-8"},{"key":"1957_CR26","doi-asserted-by":"publisher","unstructured":"Hesami O, Sistanizad M, Asadollahzade E, et al (2018) Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study. Clin Neuropharmacol 41:94\u201397. https:\/\/doi.org\/10.1097\/WNF.0000000000000280.","DOI":"10.1097\/WNF.0000000000000280"},{"key":"1957_CR27","doi-asserted-by":"publisher","unstructured":"Mazdeh M, Mahmudian R, Vafaei SY, et al (2020) Effect of Propranolol with and without Rosuvastatin on Migraine Attacks: A Triple Blind Randomized Clinical Trial. Future Neurol 15:FNL44. https:\/\/doi.org\/10.2217\/fnl-2019-0029.","DOI":"10.2217\/fnl-2019-0029"},{"key":"1957_CR28","doi-asserted-by":"publisher","unstructured":"Sherafat A, Sahebnasagh A, Rahmany R, et al (2022) The preventive effect of the combination of atorvastatin and nortriptyline in migraine-type headache: a randomized, triple-blind, placebo-controlled trial. Neurol Res 44:311\u2013317. https:\/\/doi.org\/10.1080\/01616412.2021.1981105.","DOI":"10.1080\/01616412.2021.1981105"},{"key":"1957_CR29","doi-asserted-by":"publisher","unstructured":"Medeiros FL, Medeiros PL, Valen\u00e7a MM, Dodick D (2007) Simvastatin for Migraine Prevention. Headache J Head Face Pain 47:855\u2013856. https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00824.x.","DOI":"10.1111\/j.1526-4610.2007.00824.x"},{"key":"1957_CR30","doi-asserted-by":"publisher","unstructured":"Bi Y, Zhu Y, Tang S, Huang Y (2023) Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study. J Headache Pain 24:112. https:\/\/doi.org\/10.1186\/s10194-023-01633-x.","DOI":"10.1186\/s10194-023-01633-x"},{"key":"1957_CR31","doi-asserted-by":"publisher","unstructured":"Zhang C, He Y, Liu L (2024) Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization. J Headache Pain 25:100. https:\/\/doi.org\/10.1186\/s10194-024-01805-3.","DOI":"10.1186\/s10194-024-01805-3"},{"key":"1957_CR32","doi-asserted-by":"publisher","unstructured":"Bj\u00f8rk MH, Borkenhagen S, Oteiza F, et al (2024) Comparative retention and effectiveness of migraine preventive treatments: A nationwide registry-based cohort study. Eur J Neurol 31:e16062. https:\/\/doi.org\/10.1111\/ene.16062.","DOI":"10.1111\/ene.16062"},{"key":"1957_CR33","doi-asserted-by":"publisher","unstructured":"Kang HS, Kim J-H, Kim JH, et al (2024) The Association between Statin Use and Reduced Migraine Likelihood: A Comprehensive Analysis of Migraine Subtypes and Statin Types in a Nationwide Korean Cohort. Pharmaceuticals 17:1056. https:\/\/doi.org\/10.3390\/ph17081056.","DOI":"10.3390\/ph17081056"},{"key":"1957_CR34","doi-asserted-by":"crossref","unstructured":"Sanchez Del Rio M, Cutrer FM (2023) Pathophysiology of migraine aura. In: Handbook of Clinical Neurology. Elsevier, pp 71\u201383","DOI":"10.1016\/B978-0-12-823356-6.00016-0"},{"key":"1957_CR35","doi-asserted-by":"publisher","unstructured":"Morofuji Y, Nakagawa S, Ujifuku K, et al (2022) Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer. Pharm Basel Switz 15:151. https:\/\/doi.org\/10.3390\/ph15020151.","DOI":"10.3390\/ph15020151"},{"key":"1957_CR36","doi-asserted-by":"publisher","unstructured":"Liampas I, Mylonas KS, Brotis A, et al (2021) Serum lipid abnormalities in migraine: A meta-analysis of observational studies. Headache J Head Face Pain 61:44\u201359. https:\/\/doi.org\/10.1111\/head.14039.","DOI":"10.1111\/head.14039"},{"key":"1957_CR37","doi-asserted-by":"publisher","unstructured":"Liberopoulos EN, Mikhailidis DP (2006) Could Statins Be Useful in the Treatment of Patients With Migraine? Headache J Head Face Pain 46:672\u2013675. https:\/\/doi.org\/10.1111\/j.1526-4610.2006.00293.x.","DOI":"10.1111\/j.1526-4610.2006.00293.x"},{"key":"1957_CR38","doi-asserted-by":"publisher","unstructured":"Mahmoud AN, Mentias A, Elgendy AY, et al (2018) Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects. BMJ Open 8:e020498. https:\/\/doi.org\/10.1136\/bmjopen-2017-020498.","DOI":"10.1136\/bmjopen-2017-020498"},{"key":"1957_CR39","doi-asserted-by":"publisher","unstructured":"Wang W, Zhang B (2014) Statins for the prevention of stroke: a meta-analysis of randomized controlled trials. PloS One 9:e92388. https:\/\/doi.org\/10.1371\/journal.pone.0092388.","DOI":"10.1371\/journal.pone.0092388"},{"key":"1957_CR40","doi-asserted-by":"publisher","unstructured":"Cheung BMY, Lauder IJ, Lau C-P, Kumana CR (2004) Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 57:640\u2013651. https:\/\/doi.org\/10.1111\/j.1365-2125.2003.02060.x.","DOI":"10.1111\/j.1365-2125.2003.02060.x"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-01957-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-025-01957-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-025-01957-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T12:42:02Z","timestamp":1738586522000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-025-01957-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1186\/s10194-025-01957-w","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"23"}}